MARIA
FERNANDEZ PRADA
Profesora Asociada en CC. Salud - LOSU
![Foto de MARIA](/img/nophoto.png)
![Foto de Hospital Universitario Central de Asturias](/img/noimage_org.png)
Hospital Universitario Central de Asturias
Oviedo, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Universitario Central de Asturias (30)
2024
2023
-
Executive summary - Diagnosis, treatment and prophylaxis of influenza virus infection – Consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Pediatric Infectious Diseases (SEIP), the Spanish Association of Vaccinology (AEV), the Spanish Society of Family and Community Medicine (SEMFYC) and the Spanish Society of Preventive Medicine, Public Health and Health Management (SEMPSPGS)
Anales de Pediatria, Vol. 98, Núm. 3, pp. 213-227
-
Executive summary – Diagnosis, treatment and prophylaxis of influenza virus infection – Consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Pediatric Infectious Diseases (SEIP), the Spanish Association of Vaccinology (AEV), the Spanish Society of Family and Community Medicine (SEMFYC) and the Spanish Society of Preventive Medicine, Public Health and Health Management (SEMPSPGS)
Atencion Primaria, Vol. 55, Núm. 6
-
Executive summary. Diagnosis, treatment and prophylaxis of influenza virus infection. Consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Pediatric Infectious Diseases (SEIP), the Spanish Association of Vaccinology (AEV), the Spanish Society of Family and Community Medicine (SEMFYC) and the Spanish Society of Preventive Medicine, Public Health and Health Management (SEMPSPGS)
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 2, pp. 111-122
2022
-
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain
Neurologia, Vol. 37, Núm. 8, pp. 615-630
2020
-
Evaluation of pneumococcal and influenza vaccination coverage in rheumatology patients receiving biological therapy in a regional referral hospital
Reumatologia Clinica, Vol. 16, Núm. 2P1, pp. 97-102
2019
-
Allergic contact eczema after hexavalent vaccine
Vacunas, Vol. 20, Núm. 1, pp. 34-36
-
Bronchospasm and flushing after vaccination with 23 serotype pneumococcal polysaccharide in chronic patients
Revista Espanola de Quimioterapia, Vol. 32, Núm. 2, pp. 178-182
-
Evaluation of vaccination coverage in cochlear implant patients at a referral hospital in Northern Spain
Acta Otorrinolaringologica Espanola, Vol. 70, Núm. 6, pp. 336-341
-
Intra-operative temperature monitoring with two non-invasive devices (3M Spoton® and Dräger Tcore®) in comparison with the Swan-Ganz catheter
Cirugia Cardiovascular, Vol. 26, Núm. 4, pp. 191-196
-
Reactivación del síndrome periódico asociado a criopirinas tras la vacunación en una paciente candidata a inmunosupresión
Revista Espanola de Quimioterapia
2018
-
Acute stress and anxiety in medical residents on the emergency department duty
International Journal of Environmental Research and Public Health, Vol. 15, Núm. 3
-
Adapting immunisation schedules for children undergoing chemotherapy
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 36, Núm. 2, pp. 78-83
-
Adverse reactions associated with meningococcal group B vaccine (4CMenB) in adults in special situations
Biomedical Instrumentation and Technology, Vol. 42, Núm. 5, pp. 191-196
-
Adverse reactions associated with meningococcal group b vaccine (4CMenB) in adults in special situations
Farmacia Hospitalaria, Vol. 42, Núm. 5, pp. 191-196
-
Bundles for preventing infection of surgical sites in cardiovascular units. Should topical vancomycin be included as a key measure?
Cirugia Cardiovascular, Vol. 25, Núm. 5, pp. 217-219
-
Post-vaccine exanthema in a patient with the IgG4 related disease
Revista Espanola de Quimioterapia
-
Use of hepatitis B AS04C adjuvanted vaccine in HIV patients
Revista Espanola de Quimioterapia, Vol. 31, Núm. 2, pp. 105-109
2017
-
Evaluation of the Bundle “Zero Surgical Site Infection” to Prevent Surgical Site Infection in Vascular Surgery
Annals of Vascular Surgery, Vol. 41, pp. 160-168